AzTrials
AzTrials

Respiratory Distress Syndrome, NewbornNCT06697912

Airway Flow of RAM Cannula With BCPAP in Infants

An observational study of Respiratory Distress Syndrome, Newborn and Infant, Premature, Diseases, run by Karolinska Institutet at 1 site in Vietnam.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The RAM Cannula interface is used as routine interface for newborn infants receiving CPAP treatment for respiratory distress. Compared to the standard systems that have been used for more than 50 years, the interface has high resistance and has not been extensively studied. Read more about this study

Who is it for?
Ages 0 hours to 3 months
How many people
100 participants
Where
1 siteVietnam
Study dates
19 Nov 2024to 1 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 hours to 3 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Infants treated with RAM interface and bubble CPAP system that are clinically stable, spontaneous breathing and not expected to need any urgent interventions.

Who may be able to join

  • Admitted to Phu San Hanoi Hospital Neonatology Unit
  • Support with bubble CPAP and RAM interface
  • Quiet and stable spontaneous breathing
  • Investigation team available

Who cannot join

  • Problems with routine CPAP care
  • Major congenital malformation
  • Known syndrome or neuromuscular disease
  • Circulatory instability with inotropes
  • Oxygen need >50% or CPAP >10 cm H2O
  • Surfactant given the last 6 hours or expected to be needed the next 6 hours
Show all 10Show fewer
  • Expected to need NIPPV or intubation within 6 hours
  • Recently extubated (<24 h)
  • Recent large surgical procedure (<5 days)
  • Nasal wound or irritation that hurts or is at risk of worsening during study

Trial locations and contacts

1 site in 1 country.

Vietnam1 site
  • Phu San Hanoi Hospital

    Hanoi, Hanoi, 118000

Other trials in Vietnam

About this study

Official title: Observational Study of Breathing and Flows in Bubble-CPAP Used With the RAM Cannula Interface in Newborn Infants

The RAM Cannula interface is used as routine interface for newborn infants receiving CPAP treatment for respiratory distress. Compared to the standard systems that have been used for more than 50 years, the interface has high resistance and has not been extensively studied. The delivered quality of the CPAP support is likely to be negatively affected by the interface resistance.

We hypothesise that exhalations through the device is uncommon and that the interface resistance restricts flow from the patient. If expiratory flows are uncommon the RAM interface provide support clinically comparable to other systems based on unidirectional flow such as humidified high-flow cannula.

Read more

This is a cross-sectional, observational study (no intervention) in newborn infants that are clinically stable and on respiratory support with the RAM interface connected to a bCPAP circuit. This is the most common support in the Phu San neonatal unit. The time needed for data collection is short and collection is expected to take approximately five minutes (less than 15 minutes) in a quiet infant. The collection can be planned to minimize disturbances for the infant, parents and staff. For example, the busiest times of the day can be avoided to not intervene with daily care, ward rounds or examinations of the infant.

Data on flow and pressure will be collected within the respiratory support circuit at the connection to the RAM interface. The measurements are passive, and no tests or manipulation of the infant is planned. There will be brief interruptions (<1 min) in respiratory support when the meters are connected. Similar interruptions are very common and occurs several times per day during normal care.

Data will be collected in case report forms (CRF) with REDCap electronic data capture tool. All personal identifiers will be removed before data export from REDCap and further analysis only using enrolment numbers.

Background variables describing the pregnancy, delivery and the infant will be collected. We also will record details of the RAM-cannula interface, such as size, protective dressing, gastric feeding tube, obvious leak at nares and mouth.

During the measurement the infant will be monitored for vital signs and any problems will be addressed and recorded. This includes oxygen need, CPAP support and breathing problems. The flow and pressure data for one minute of quiet breathing will be stored locally with the enrolment number as identifier. The analysis after collection of flow and pressure will include average flow in the CPAP circuit, the flow to the patient, average absolute leak and delivered pressure. If a variation with breathing can be seen this will be described. These output variables directly relate to the research questions.

  1. What flows and pressure can be observed in the breathing circuit? [Measured average flows, pressure and variability between patients]
  2. Do infants exhale through the RAM interface? [Measured expiratory flows at the interface]
  3. What is the level of leak for the interface? [Measured absolute leak]

The RAM cannula interface has been widely introduced but is not CE-marked for CPAP support. It has an advantage of being more comfortable and light weight with less nasal injury in most trials. The high resistance of the RAM interface has been discussed as problematic by several authors, but the clinical importance is not known. Comparing RAM interface to other CPAP interfaces in clinical trials is difficult and, if RAM has a treatment effect similar to HHFNC, very large trials of high quality would be needed.

The described study will generate new knowledge on the RAM interface by describing patient flow through the interface and illustrate the importance of resistance and leak. The study is not strictly a physiological study but investigate flow in an airway interface. The most likely outcome is that exhalation is uncommon, and this would support that the RAM interface has more similarities with HHFNC than conventional CPAP.

Keywords
Continuous Positive Airway Pressure, Respiratory Therapy
Medical subject headings
Respiratory Distress Syndrome, Newborn, Infant, Premature, Diseases, Infant, Newborn, Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06697912
Study groupRoleWhat they receive
Infant treated with bubble CPAP and receiving blended air/oxygenNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Airway flow in RAM interface

    Average airway flow (L/min) in a quiet breathing infant

    Measured: 60 seconds

Secondary outcomes (3)
  1. Pressure at Y-piece connector of RAM interface

    Average pressure (cm H2O) over 60 seconds in a quiet breathing infant

    Measured: 60 seconds

  2. Fresh gas flow to Y-piece connector for RAM interface

    Average flow (L/min) over 60 seconds in a quiet breathing infant

    Measured: 60 seconds

  3. Exhalation through Y-piece connector for RAM interface

    Number of breaths (ratio) with an expiratory flow of (duration >0.1 ms) over 60 seconds in a quiet breathing infant

    Measured: 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2024
  2. Study start19 Nov 2024
  3. Primary completion1 Jun 2025
  4. Study completion1 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06697912
Sponsor's protocol ID
1758 CN/PS
Status last verified
Jun 2025
First submitted
18 Nov 2024
Last updated
25 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The datasets used and/or analysed during the current study will be available from the principal investigator on reasonable request after publication of results.

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Distress Syndrome, Newborn and Infant, Premature, Diseases, run by Karolinska Institutet at 1 site in Vietnam.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Airway flow in RAM interface (time frame: 60 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in